Find a Clinical Trial
Filter
DEFENDO Long-Term Follow-Up Study
Neurotrophic keratitis
All genders
18+
Recruiting now
Department of Ophthalmology
SEER-2
Neurotrophic keratitis
All genders
18+
Recruiting now
Department of Ophthalmology
Gemini 1
Multiple sclerosis
All genders
18-55
Recruiting now
Department of Neurology
Hercules
Multiple sclerosis
All genders
18-60
Recruiting now
Department of Neurology
PERSEUS
Multiple sclerosis
All genders
18-55
Recruiting now
Department of Neurology
POETYK SjS-1
Sjogren's syndrome
All genders
18+
Recruiting now
Department of Ophthalmology
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)
Bladder cancer
All genders
18+
Recruiting now
Department of Medicine, Cancer Center
BALATON
Macular degeneration
All genders
18+
Recruiting now
Department of Ophthalmology
Belvedere
Macular degeneration
All genders
50+
Recruiting now
Department of Ophthalmology
KPI-012-C-001
Corneal disorders
All genders
18+
Recruiting now
Department of Ophthalmology